Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 4 2Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Papillomavirus Infections 2Rheumatic Diseases 1Persistent Infection 1Neoplasms 1HIV Infections 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7human papillomavirus vaccine, L1 type 16, 18 6Papillomavirus Vaccines 4Vaccines 2Engerix-B 2adacel 1Vaccines, Synthetic 1Tetanus Toxoid 1Methods 1Hepatitis A Vaccines 1Educational Status 1Early Intervention, Educational 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Papillomavirus Infections × Vaccines × Clear all
NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Xiamen Innovax Biotech Co., Ltd

Phase 4 Completed
540 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01031069 2020-07-21

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

GlaxoSmithKline

Phase 4 Completed
873 enrolled 34 charts
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡